Popular depictions of ECT owe more to film than to fact. A recent review in Harvard Review of Psychiatry, by Kritzer and colleagues, sets out what the clinical evidence actually shows.
ECT is a medical procedure performed under general anaesthetic. A carefully controlled electrical current is passed through the brain to produce a brief, generalised seizure. The person is asleep throughout, and does not experience the seizure in the way older films suggest.
The review describes ECT as the most effective treatment available for a number of serious psychiatric conditions. These include depression that has not responded to other treatments, bipolar depression, mania, catatonia, and schizophrenia that has not responded to clozapine.
The technique has changed substantially since the 1930s. A great deal of effort has gone into making it safer and reducing its effects on memory and thinking. The review is careful to note that these effects have not been eliminated altogether, and that exactly how ECT works in the brain remains an open question for researchers.
Understanding what a procedure involves tends to make it less daunting than imagining it. If ECT has come up in conversation with your treating team, or for someone you care about, asking them to explain the practical steps is a reasonable request, and a sensible place to begin.
What the procedure involves
Electroconvulsive therapy (ECT) is a medical procedure in which a controlled electrical current passes through the brain while the patient is under general anaesthesia: fully unconscious, with muscles relaxed by medication. The current triggers a generalised seizure, a brief and widespread burst of coordinated electrical activity across the brain. The patient is not conscious during the seizure, and modern practice uses muscle relaxants precisely so the body does not convulse in the way older depictions suggest.
The paper discussed here, by Kritzer and colleagues, is a narrative review. That means it is a structured summary of existing research on a topic, written to give clinicians and researchers a sense of where the science currently stands. It does not test a new hypothesis of its own; instead, it draws together findings from many separate studies.
What the review covers
The authors describe ECT as the most effective treatment available for a number of serious psychiatric conditions. These include treatment-resistant depression (depression that has not improved with standard treatments such as medication or psychotherapy), bipolar depression, mania, catatonia (a state involving disturbances in movement and responsiveness), and schizophrenia that has not responded to clozapine. Clozapine itself is usually reserved for schizophrenia that has already proven resistant to other antipsychotic medications. Being named the most effective option for these presentations carries weight, given that these are cases where other treatments have already been tried and have not worked.
The review also addresses ECT's known effects on cognition, meaning memory and thinking. It acknowledges that these effects are real and well documented, and that they persist even after decades of technical refinement to the procedure.
Why understanding mechanisms matters
A central argument of the paper is that researchers need a better grasp of the physiologic, cellular, and molecular mechanisms behind ECT. In plain terms, this means understanding what is actually happening in the brain, from large-scale patterns of brain activity down to the behaviour of individual cells and molecules, to produce the treatment's therapeutic effect. The authors frame this as necessary groundwork. If we understand why ECT works, we are in a much stronger position to adjust it so that it works better and produces fewer side effects, rather than refining it through trial and error alone.
Consistent with this argument, the review points to clinical trials that manipulate specific technical variables as a key route toward improving outcomes. These include the electrical parameters used during treatment, where electrodes are placed on the scalp, medications given alongside ECT, and which patients are selected to receive it. This points to a field that is still actively investigating how to deliver ECT in the best possible way, rather than one working from a single fixed protocol.
What this does, and doesn't, tell us
As a narrative review, this paper's job is to summarise and organise existing knowledge, not to report new experimental results. It does not specify particular mechanisms, exact effect sizes, or head-to-head comparisons between techniques: those details sit within the individual studies the review draws together. What it does offer is a clear statement that ECT remains a highly effective but imperfect tool, one with real cognitive costs and an active research agenda aimed at making it safer and more precisely targeted.
If ECT has come up in your own care or in a loved one's, it is entirely reasonable to ask your treating team detailed questions about what is being proposed and why. And if you are struggling, please don't hesitate to reach out to a mental health professional for support.